Lung Cancer News

Nearly 50% of patients with pretreated, locally advanced non-small cell lung cancer harboring a KRAS G12C mutation responded to treatment with glecirasib, findings from a phase 2 study conducted in China showed.

Researchers at Columbia University's Herbert Irving Comprehensive Cancer Center are investigating a lung cancer treatment that can be delivered directly to the lungs.

The FDA approved alectinib as an adjuvant treatment for patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer following tumor resection and detection by an FDA-approved test.

Most adults have not tested their homes for radon, nor have they taken action to reduce radon exposure despite its link to cancer, a survey showed.

The FDA granted fast track designation to PT217, a novel bispecific antibody, for the treatment of adults with extensive-stage small cell lung cancer, according to a release from the manufacturer.

Patients with multimorbidity and limited life expectancy are often unaware of the risks of lung cancer screening, and clinicians might be hesitant to discuss it, according to a pair of studies published in the Annals of Family Medicine.

Adagrasib monotherapy improved PFS and overall response rate among adults with pretreated locally advanced or metastatic non-small cell lung cancer harboring a KRASG12C

Surgeons at Northwestern Medicine Canning Thoracic Institute have performed what is believed to be the first-ever combined lung-liver transplant for a patient with advanced lung cancer, according to medical staff at Northwestern Medicine.

The combination of pembrolizumab and maintenance olaparib failed to significantly improve survival outcomes among adults with metastatic nonsquamous non-small cell lung cancer, according to the agent’s manufacturer.

Patients with positive lung cancer screening findings frequently delay their first follow-up visit, according to results published in Annals of the American Thoracic Society.